VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,274 | -82.2% | 295 | -50.0% | 0.00% | – |
Q2 2023 | $7,166 | +37.2% | 590 | +100.0% | 0.00% | – |
Q1 2023 | $5,222 | +104340.0% | 295 | 0.0% | 0.00% | – |
Q4 2022 | $5 | -99.9% | 295 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | 0.0% | 295 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -50.0% | 295 | -50.0% | 0.00% | – |
Q1 2022 | $10,000 | +100.0% | 590 | +100.0% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 295 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 295 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | +50.0% | 295 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | 0.0% | 295 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | – | 295 | – | 0.00% | – |
Q3 2020 | $0 | – | 0 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $37,000 | -15.9% | 1,425 | -25.0% | 0.00% | 0.0% |
Q3 2018 | $44,000 | +144.4% | 1,900 | +90.0% | 0.00% | +100.0% |
Q3 2017 | $18,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |